Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

When it comes to treating kidney stones, two popular laser systems are neck and neck. A new randomized trial found that the Holmium:YAG and thulium fiber lasers delivered nearly identical stone-free rates, procedure times, and quality-of-life improvements. Bottom line: surgeons can rely on whichever laser they know best.
Choosing between two leading laser systems for kidney stone surgery just got a lot simpler. A randomized controlled trial across five US tertiary care centers compared the pulse-modulated Holmium:YAG (Ho:YAG) laser and the thulium fiber laser (TFL) in 178 adults undergoing retrograde intrarenal surgery for kidney stones sized 5–20 mm. The verdict? They're essentially equivalent.
Stone-free rates, procedure duration, laser energy used, and complication rates were all statistically similar between the two groups. Importantly, patients in both groups reported significant improvements in health-related quality of life after surgery — a win no matter which laser was used. All observed complications were minor, with most involving post-operative pain requiring an ED visit.
By the Numbers
Why it matters: With both lasers performing equally well, hospitals and surgeons don't need to overhaul their equipment or training. Institutional preference and surgeon familiarity can safely guide the choice — simplifying decision-making without compromising patient outcomes.